77 Ill. Adm. Code 690.540
Multi-drug Resistant Organisms Considered to be of Epidemiologic Importance Due to Either Severity of Clinical Disease, Potential for Transmission of Genetic Elements, or Opportunities for Effective Control Efforts (Reportable by telephone, facsimile, or electronically as soon as possible, within three days)
Section 690
Section 690.540Â Multi-drug
Resistant Organisms Considered to be of Epidemiologic Importance Due to Either
Severity of Clinical Disease, Potential for Transmission of Genetic Elements,
or Opportunities for Effective Control Efforts (Reportable by telephone,
facsimile, or electronically as soon as possible, within three days)
a)Â Â Â Â Â Â Â Â Control
of Case
1)Â Â Â Â Â Â Â Â Patients in health care facilities, including, but not limited
to, long-term acute care hospitals and skilled nursing facilities, should
comply with the local health authority's recommendations for control measures
as supported by the Department or the CDC procedures and best practices for
control of transmission.
2)Â Â Â Â Â Â Â Â The health care facility shall confirm notification to a
receiving facility before admission or transfer and include in admission and
transfer orders if the patient is positive for an MDRO, or if the patient was screened
or tested for an MDRO and the results are pending and make notification of
results once testing is completed.
b)Â Â Â Â Â Â Â Â Control
of Contacts
Health care
facilities should comply with the local health authority's recommendations for prevention
and control measures and outbreak response as supported by the Department or
CDC procedures and best practices for control of transmission.
c)Â Â Â Â Â Â Â Â Laboratory
Testing
1)Â Â Â Â Â Â Â Â Laboratories shall report to the local health authority
patients who have a positive result on any laboratory test indicative of and
specific for detecting infection or colonization of MDROs deemed to be of
public health importance.
2)Â Â Â Â Â Â Â Â If deemed necessary by the local health authority or the
Department, laboratories shall forward clinical or environmental specimens to
the Department's laboratory for further testing.